First, thyroid function must be stable and adequately treated
Retatrutide has not received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA), and no marketing authorisation application has been approved as of the date of publication of this article
PT-141 allows more flexibility and spontaneity because its influence lingers in the neurological pathways, not only in the bloodstream
And, if you are paying in cash for the Zepbound KwikPen, the prices start at $299 per month for the 2.5 mg dose and scale up depending on the dose you need
Today, brand-name tirzepatide remains expensive, with list prices around $1,087 per month for Zepbound and about $1,112 per month for Mounjaro